Please login to the form below

Not currently logged in
Email:
Password:

Microsoft creates ‘Emma’ to aid with Parkinson’s

Prototype watch reduces uncontrollable shaking

Project Emma

Microsoft has unveiled a prototype watch named ‘Project Emma’ for people suffering with Parkinson’s disease.

The tech firm’s wearable is designed to reduce uncontrollable shaking that’s brought on by the progressive deterioration of nerve cells in the brain.

It does this through small vibration motors inside the watch that stops the brain from creating as many tremors.

Haiyan Zheg, innovation director at Microsoft Research Cambridge, explained: “I’ve been chatting with Emma [a friend and graphic designer with Parkinson’s], researchers and experts to put together a deeper piece of research on how AI and wearables can better support people with Parkinson’s to manage their symptoms and medication intake.”

“This would be an extension of the original Emma Watch project but could be quite an impactful piece of work, however, it’s still only in the proposal stage.”

The watch was introduced at Microsoft Build conference in Seattle and the company will start initial trials of the device in London.

Article by
Gemma Jones

13th June 2017

From: Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics